P450 isotypes/enzyme inducers | concentration (μM) | mRNA fold change (mean ± SD) | |||
---|---|---|---|---|---|
 |  | HepG2 | P-hepatocyte | hMSC | Hep-like cell |
CYP1A1 | Â | Â | Â | Â | Â |
omeprazole | 50 | 4.05 ± 0.38* | 11.13 ± 0.34* | 2.09 ± 0.30 | 2.13 ± 0.15 |
dexamethasone | 25 | 1.11 ± 0.13 | 19.68 ± 0.46* | 3.10 ± 0.33* | 12.86 ± 0.39* |
CYP1A2 | Â | Â | Â | Â | Â |
omeprazole | 50 | 3.33 ± 0.14* | 6.44 ± 0.80 | 1.67 ± 0.12 | 2.37 ± 0.13 |
dexamethasone | 25 | 1.17 ± 0.02 | 13.62 ± 2.84* | 3.82 ± 0.96* | 5.63 ± 0.65* |
CYP2B6 | Â | Â | Â | Â | Â |
rifampicin | 40 | 25.82 ± 1.30* | 35.16 ± 2.76** | 1.46 ± 0.10 | 30.70 ± 5.36** |
dexamethasone | 25 | 2.58 ± 0.72 | 41.49 ± 4.58** | 3.98 ± 0.71* | 24.25 ± 2.30* |
CYP2D6 | Â | Â | Â | Â | Â |
dexamethasone | 25 | 1.26 ± 0.10 | 5.70 ± 1.29 | 2.68 ± 0.43 | 2.90 ± 0.73 |
CYP2C9 | Â | Â | Â | Â | Â |
rifampicin | 40 | 1.42 ± 0.25 | 15.25 ± 2.51* | 2.03 ± 0.22 | 7.78 ± 1.82* |
CYP2C19 | Â | Â | Â | Â | Â |
rifampicin | 40 | 1.87 ± 0.11 | 29.05 ± 2.02** | 2.42 ± 0.61 | 19.01 ± 2.51* |
CYP2C8 | Â | Â | Â | Â | Â |
rifampicin | 40 | 9.07 ± 1.03* | 24.40 ± 2.48* | 3.03 ± 0.62* | 12.28 ± 0.81* |
CYP3A4 | Â | Â | Â | Â | Â |
rifampicin | 40 | 39.43 ± 5.53** | 69.50 ± 6.84** | 3.64 ± 1.82* | 43.29 ± 3.27** |
dexamethasone | 25 | 23.18 ± 7.25** | 72.27 ± 5.64** | 2.87 ± 0.96 | 84.10 ± 9.25** |
artemisinine | 50 | 48.18 ± 6.80** | 59.28 ± 8.41** | 0.89 ± 0.07 | 53.54 ± 1.37** |
CYP2E1 | Â | Â | Â | Â | Â |
ethanol | 88 | 4.59 ± 0.53* | 24.23 ± 0.41* | 1.46 ± 0.19 | 10.74 ± 2.10* |